NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+49.26%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.93B
AUM Growth
+$1.93B
Cap. Flow
-$74.5M
Cap. Flow %
-3.87%
Top 10 Hldgs %
81.87%
Holding
41
New
4
Increased
–
Reduced
3
Closed
2

Top Buys

1
AKAO
Achaogen, Inc.
AKAO
$17.9M
2
CASC
Cascadian Therapeutics, Inc.
CASC
$10.1M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$9.95M
4
AKTX
Akari Therapeutics
AKTX
$6.1M

Top Sells

1
OPWR
OPOWER INC COM STK (DE)
OPWR
$61.3M
2
GRPN icon
Groupon
GRPN
$36M
3
OREX
Orexigen Therapeutics, Inc.
OREX
$14.4M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$817K

Sector Composition

1 Healthcare 77.16%
2 Technology 7.27%
3 Communication Services 5.59%
4 Consumer Discretionary 1.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$864M 44.82% 10,275,113 – –
GRPN icon
2
Groupon
GRPN
$1.06B
$108M 5.59% 33,109,905 -11,063,048 -25% -$36M
SENS icon
3
Senseonics Holdings
SENS
$374M
$103M 5.37% 26,303,189 – –
ARDX icon
4
Ardelyx
ARDX
$1.53B
$103M 5.34% 11,792,631 – –
DERM
5
DELISTED
Dermira, Inc.
DERM
$103M 5.32% 3,506,649 – –
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
$80.5M 4.18% 9,880,999 – –
EPZM
7
DELISTED
Epizyme, Inc
EPZM
$64.1M 3.33% 6,260,851 – –
CBIO
8
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$62.4M 3.24% 8,584,128 – –
NVRO
9
DELISTED
NEVRO CORP.
NVRO
$48.7M 2.53% 660,428 – –
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
$41.5M 2.16% 1,792,207 – –
CRCM
11
DELISTED
CARE.COM, INC.
CRCM
$38.1M 1.98% 3,260,989 – –
KA
12
DELISTED
Kineta, Inc. Common Stock
KA
$37.5M 1.95% 3,095,240 – –
LXRX icon
13
Lexicon Pharmaceuticals
LXRX
$400M
$34.2M 1.77% 2,382,286 – –
ELGX
14
DELISTED
Endologix Inc
ELGX
$31M 1.61% 2,490,204 – –
HIVE
15
DELISTED
AEROHIVE NETWORKS, INC.
HIVE
$31M 1.61% 4,681,455 – –
TRVN
16
DELISTED
Trevena, Inc.
TRVN
$24M 1.25% 3,811,691 – –
AKAO
17
DELISTED
Achaogen, Inc.
AKAO
$17.9M 0.93% +4,715,128 New +$17.9M
EXEL icon
18
Exelixis
EXEL
$10.1B
$17.2M 0.89% 2,207,000 – –
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$15.6M 0.81% 1,139,890 – –
SYBX icon
20
Synlogic
SYBX
$17M
$12.7M 0.66% 2,974,811 – –
CASC
21
DELISTED
Cascadian Therapeutics, Inc.
CASC
$10.1M 0.52% +10,750,000 New +$10.1M
AVEO
22
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$9.95M 0.52% +10,362,694 New +$9.95M
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
$8.52M 0.44% 2,141,308 – –
TCON
24
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$8.28M 0.43% 1,889,652 – –
RIGL icon
25
Rigel Pharmaceuticals
RIGL
$697M
$7.23M 0.38% 3,243,150 – –
1
2